.png)
About Us
Founded in 2020, SVG Pharma was established to bridge the gap between scientific research and the development of emerging therapeutic technologies. Since then, we have supported clinical programs from early concept through to late-phase trials, delivering evidence-based insights, operational precision, and regulatory guidance across Australia and internationally.
​
Our approach combines scientific rigour, innovative technology, and lean operational models to deliver cost-effective, high-quality clinical trials across plant-based therapeutics, microbiome interventions, and mental health treatments.
Our Expertise
Our leadership team combines medical, regulatory, and operational experience across the full spectrum of the emerging therapeutic development — from cultivation and GMP-compliant manufacturing to clinical validation and regulatory submission.
Dr. Christopher Schneider – Clinical Lead & Gastroenterologist
Dr. Schneider is a Canadian-trained Gastroenterologist and Principal Investigator with expertise in hepatology, nutrition, and chronic gastrointestinal disorders. He leads clinical research into cannabinoid therapies, bringing extensive experience in evidence-based medicine, patient safety, and the integration of emerging treatments into clinical practice. His work continues to inform the development of regulated, patient-focused approaches to novel therapeutics.
Richard Palesh - Cannabis Industry & Regulatory Specialist
Richard is a senior regulatory and industry specialist with expertise across the entire medicinal cannabis lifecycle, from cultivation and GMP manufacturing to clinical development and regulatory submission. He guides Phase I–IV clinical trial strategy, develops CTD/DMF dossiers, and ensures compliance with TGA and international regulatory frameworks, bridging operational execution with regulatory strategy to deliver reliable, evidence-based clinical programs.
Our extended multidisciplinary team brings together scientists, clinical operations specialists, and regulatory advisors, each with extensive experience in emerging therapeutics research, ensuring every study is executed with scientific precision, regulatory compliance, and operational efficiency.
Our Services
At SVG Pharma, we deliver customised clinical research services tailored to each sponsor’s goals. From study design to regulatory submission, we deliver efficient, compliant, and evidence-driven outcomes for a wide range of emerging therapies.
Clinical Research Services
-
Phase I–IV clinical trials for emerging therapeutics
-
​Pharmacokinetic (PK) and pharmacodynamic (PD) studies
-
Protocol design, statistical planning and risk mitigation
-
Site selection, monitoring and trial management
-
Data management, analysis, and reporting
-
​GMP-compliant manufacturing support, leveraging our expertise to ensure quality, regulatory alignment, and seamless integration with clinical programs
Regulatory and Ethics Support
-
Human Research Ethics Committee (HREC) consultation and submissions
-
TGA regulatory guidance and compliance support
-
CTD (Common Technical Document) preparation for product registration
-
DMF (Drug Master File) development and submission support
-
GMP/GCP auditing and guidance
Scientific Consultation
-
Study design for emerging phytotherapeutics
-
Formulations, dosing, and safety advisory
-
Pharmacokinetic study design support for plant-derived and other novel products
Specialisation
-
Medicinal cannabis clinical trials (Schedules 3, 4, & 8)
-
Deep understanding of emerging therapeutics for medicine registrations
-
Strategic partnership models for medicinal cannabis product development
Global Support, Local Expertise
We partner with sponsors worldwide to generate robust, regulator-ready evidence that accelerates market access for innovative therapies.
With a deep understanding of Australian and international regulatory standards, we support cross-border studies and multi-jurisdictional submissions with confidence and clarity.
Patient & Ethical Focus
Patient safety and ethical integrity are central to every study we conduct. Our trials are designed and executed with strict ethical oversight, ensuring participant wellbeing, data integrity, and regulatory compliance at every stage.
​​
We are committed to conducting research that not only meets scientific and commercial objectives, but also upholds the highest standards of responsibility and transparency.
Why collaborate with SVG
We believe meaningful research thrives on collaboration, innovation, and compliance. Our integrated suite of services empowers sponsors and researchers to navigate complex clinical and regulatory landscapes of emerging therapeutics with confidence and clarity.
​
By combining scientific expertise, lean operational models, and advanced technologies, we deliver trials that are efficient, cost-effective, and insight-driven, helping sponsors transform innovation into evidence-based therapies.
​
We welcome collaborations with organisations developing medicinal cannabis, plant-based, microbiome, or mental health therapeutics.